Q3 2016 Holdings
Filed 2016-11-14 | 44 holdings | $32.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Axogen Inc(AXGN) | COM | 05463X106 | $18.1M | 2,000,000 | 55.1% |
| Agios Pharmaceuticals(AGIO) | COM | 00847X104 | $6.9M | 130,000 | 20.9% |
| Codexis Inc(CDXS) | COM | 192005106 | $5.2M | 1,170,000 | 15.8% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $2.5M | 160,000 | 7.7% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $23.3K | 785,000 | 0.1% |
| Ariad Pharmaceuticals Inc | COM | 04033A100 | $14.3K | 1,045,000 | 0.0% |
| Medgenics Inc | COM NEW | 58436Q203 | $10.0K | 1,800,000 | 0.0% |
| Fibrogen Inc(FGENEUR) | COM | 31572Q808 | $6.8K | 330,000 | 0.0% |
| Foamix Pharmaceuticals LTD | SHS | M46135105 | $5.8K | 630,000 | 0.0% |
| Cara Therapeutics Inc(CARAEUR) | COM | 140755109 | $5.6K | 675,000 | 0.0% |
| Cynapsus Therapeutics Inc | COM PAR NO PAR | 23257Y859 | $5.0K | 125,000 | 0.0% |
| Horizon Global Corp | COM | G4617B105 | $5.0K | 275,000 | 0.0% |
| Eagle Pharmaceuticals Inc(EGRX) | COM | 269796108 | $4.9K | 70,000 | 0.0% |
| Imprimis Pharmaceuticals Inc | COM NEW | 45323A201 | $4.6K | 1,215,381 | 0.0% |
| Global Blood Therapeutics in | COM | 37890U108 | $4.6K | 200,000 | 0.0% |
| Protalix Biotherapeutics Inc | COM | 74365AAB7 | $4.6K | 8,070,000 | 0.0% |
| Macrogenics Inc(MGNX) | COM | 556099109 | $4.3K | 145,000 | 0.0% |
| Chimerix Inc(CMRXEUR) | COM | 16934W106 | $4.3K | 780,000 | 0.0% |
| Aquinox Pharmaceuticals Inc | COM | 03842B101 | $4.1K | 310,000 | 0.0% |
| Adamas Pharmaceuticals Inc(ADMSEUR) | COM | 00548A106 | $4.1K | 250,000 | 0.0% |
| Immunomedics Inc(IMMU) | COM | 452907108 | $3.9K | 1,200,000 | 0.0% |
| Inotek Pharmaceuticals Corp | COM | 45780VAA0 | $3.8K | 400,000 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $3.3K | 410,000 | 0.0% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $3.0K | 50,000 | 0.0% |
| Edge Therapeutics Inc | COM | 279870109 | $2.9K | 280,000 | 0.0% |
| Loxo Oncology Inc | COM | 548862101 | $2.9K | 110,000 | 0.0% |
| Trillium Therapeutics Inc | COM NEW | 89620X506 | $2.6K | 175,000 | 0.0% |
| Zogenix Inc | COM NEW | 98978L105 | $2.5K | 220,000 | 0.0% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $2.5K | 35,000 | 0.0% |
| Proteostasis Therapeutics in | COM | 74373B109 | $2.4K | 152,000 | 0.0% |
| Lion Biotechnologies Inc | COM | 53619R102 | $2.3K | 280,000 | 0.0% |
| Corium Intl Inc | COM | 21887L107 | $2.3K | 400,000 | 0.0% |
| Amarin Corp PLC | SPONS ADR NEW | 023111206 | $2.2K | 700,000 | 0.0% |
| Neuroderm LTD | ORD SHS | M74231107 | $1.8K | 98,500 | 0.0% |
| Nabriva Therapeutics AG | SPONSORED ADR | 62957M104 | $1.7K | 239,500 | 0.0% |
| Innocoll Hldgs PLC | SHS | G4783X105 | $1.6K | 269,100 | 0.0% |
| Affimed N V | COM | N01045108 | $1.2K | 430,000 | 0.0% |
| Intec Pharma LTD Jerusalem | COM | M53644106 | $1.0K | 175,000 | 0.0% |
| Tenax Therapeutics Inc | COM | 88032L100 | $905 | 390,000 | 0.0% |
| Portola Pharmaceuticals Inc | COM | 737010908 | $795 | 35,000 | 0.0% |
| Abeona Therapeutics Inc(ABEO1EUR) | COM | 00289Y107 | $600 | 100,000 | 0.0% |
| Amag Pharmaceuticals Inc(AMAG) | COM | 00163U106 | $368 | 15,000 | 0.0% |
| Biolinerx LTD | SPONSORED ADR | 09071M106 | $288 | 250,000 | 0.0% |
| Depomed Inc | COM | 249908104 | $41 | 1,650 | 0.0% |